Search research articles
Contact Us
Filters
Showing results (61-70 of 86) with videos related to
Page
of 9
Sort By:
FEMS Immunology and Medical Microbiology
|
September 25, 1999
Vgamma9/Vdelta2 T cell activation induced by bacterial low molecular mass compounds depends on the 1-deoxy-D-xylulose 5-phosphate pathway of isoprenoid biosynthesis
H Jomaa, J Feurle, K Lühs, et al.
Clinical and Experimental Rheumatology
|
October 31, 2015
Combination of B cell biomarkers as independent predictors of response in patients with rheumatoid arthritis treated with rituximab
H-P Tony, P Roll, H E Mei, et al.
Scandinavian Journal of Rheumatology
|
September 11, 2020
Biomarker-guided application of low-dose anakinra in an acute respiratory distress syndrome patient with severe COVID-19 and cytokine release syndrome
M J Steinhardt, S Wiebecke, D Weismann, et al.
European Journal of Immunology
|
November 22, 1997
Host cell factor CD59 restricts complement lysis of Plasmodium falciparum-infected erythrocytes
J Wiesner, H Jomaa, M Wilhelm, et al.
Zeitschrift Fur Rheumatologie
|
August 13, 2016
[The first biologic for rheumatoid arthritis: factors influencing the therapeutic decision]
D Pattloch, A Richter, B Manger, et al.
Annals of Hematology
|
September 1, 1992
Gamma/delta receptor-expressing T-cell clones from a cutaneous T-cell lymphoma suppress hematopoiesis
M Wilhelm, P Meyer, C Batram, et al.
Annals of the Rheumatic Diseases
|
May 10, 2017
Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort
Y Meissner, A Richter, B Manger, et al.
Scandinavian Journal of Rheumatology
|
September 27, 2019
T cells, natural killer cells, and γδT cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapy
E C Schwaneck, R Renner, L Junker, et al.
Annals of the Rheumatic Diseases
|
January 8, 2009
Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide
A Strangfeld, F Hierse, J Kekow, et al.
Annals of the Rheumatic Diseases
|
July 16, 2008
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
P Emery, E Keystone, H P Tony, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 86) with videos related to
Sort By:
Page
of 9
FEMS Immunology and Medical Microbiology
|
September 25, 1999
Vgamma9/Vdelta2 T cell activation induced by bacterial low molecular mass compounds depends on the 1-deoxy-D-xylulose 5-phosphate pathway of isoprenoid biosynthesis
H Jomaa, J Feurle, K Lühs, et al.
Clinical and Experimental Rheumatology
|
October 31, 2015
Combination of B cell biomarkers as independent predictors of response in patients with rheumatoid arthritis treated with rituximab
H-P Tony, P Roll, H E Mei, et al.
Scandinavian Journal of Rheumatology
|
September 11, 2020
Biomarker-guided application of low-dose anakinra in an acute respiratory distress syndrome patient with severe COVID-19 and cytokine release syndrome
M J Steinhardt, S Wiebecke, D Weismann, et al.
European Journal of Immunology
|
November 22, 1997
Host cell factor CD59 restricts complement lysis of Plasmodium falciparum-infected erythrocytes
J Wiesner, H Jomaa, M Wilhelm, et al.
Zeitschrift Fur Rheumatologie
|
August 13, 2016
[The first biologic for rheumatoid arthritis: factors influencing the therapeutic decision]
D Pattloch, A Richter, B Manger, et al.
Annals of Hematology
|
September 1, 1992
Gamma/delta receptor-expressing T-cell clones from a cutaneous T-cell lymphoma suppress hematopoiesis
M Wilhelm, P Meyer, C Batram, et al.
Annals of the Rheumatic Diseases
|
May 10, 2017
Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort
Y Meissner, A Richter, B Manger, et al.
Scandinavian Journal of Rheumatology
|
September 27, 2019
T cells, natural killer cells, and γδT cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapy
E C Schwaneck, R Renner, L Junker, et al.
Annals of the Rheumatic Diseases
|
January 8, 2009
Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide
A Strangfeld, F Hierse, J Kekow, et al.
Annals of the Rheumatic Diseases
|
July 16, 2008
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
P Emery, E Keystone, H P Tony, et al.
Page
of 9